You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Hodgkin Disease
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    U
    Recruiting
    • Adult T-cell Leukemia-Lymphoma
    • ATLL
    • Miami, Florida
      University of Miami
    2022-01-24
    Jan 24, 2022
    N
    Completed
    • T Cell Leukemia, Adult
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-01-26
    Jan 26, 2022
    N
    Recruiting
    • Multiple Myeloma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      N
      Active, not recruiting
      • Adult T-Cell Leukemia (ATL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-01-13
      Jan 13, 2022
      N
      Not yet recruiting
      • Adult T-cell Leukemia/Lymphoma
      • +4 more
      • CC-486 (5-azacitidine)
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Active, not recruiting
      • Adult T-Cell Lymphoma/Leukemia
      • +2 more
      • Recombinant human Interleukin-15 (rhIL-15)
      • Mogamulizumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2021-11-17
      Nov 17, 2021
      U
      Recruiting
      • Lymphoma
      • +2 more
      • Brentuximab Vedotin
      • CHEP
      • Hollywood, Florida
      • +3 more
      2021-08-12
      Aug 12, 2021
      O
      Active, not recruiting
      • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
      • Yamagata, Japan
        Yamagata University Hospital
      2022-02-21
      Feb 21, 2022
      N
      Completed
      • T-Cell Lymphoma Relapsed
      • +4 more
      • IL-15 plus alemtuzumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-07-10
      Jul 10, 2021
      J
      Recruiting
      • Recurrent Adult T-Cell Leukemia/Lymphoma
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      2021-10-07
      Oct 7, 2021
      D
      Recruiting
      • T-cell Lymphoma
      • +5 more
      • Brentuximab vedotin
      • Ann Arbor, Michigan
      • +4 more
      2022-02-02
      Feb 2, 2022
      N
      Recruiting
      • Hairy Cell Leukemia (HCL)
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-04-07
        Apr 7, 2022
        W
        Active, not recruiting
        • Adult Lymphocyte Depletion Hodgkin Lymphoma
        • +16 more
        • 6,8-bis(benzylthio)octanoic acid
        • bendamustine hydrochloride
        • Winston-Salem, North Carolina
        • +1 more
        2021-10-28
        Oct 28, 2021
        D
        Active, not recruiting
        • Adult T-cell Leukemia/Lymphoma
        • Valemetostat Tosylate
        • Nagoya-shi, Aichi, Japan
        • +23 more
        2022-01-11
        Jan 11, 2022
        M
        Active, not recruiting
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +20 more
        • Scottsdale, Arizona
        • +1 more
        2022-02-03
        Feb 3, 2022
        H
        Completed
        • Adult T-Cell Lymphoma (ATL)
        • Fukuoka, Japan
        • +18 more
        2020-10-02
        Oct 2, 2020
        N
        Completed
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +35 more
        • Akt inhibitor MK2206
        • laboratory biomarker analysis
        • Houston, Texas
          M D Anderson Cancer Center
        2020-10-14
        Oct 14, 2020
        N
        Terminated
        • Leukemia, Adult T-Cell
        • Denileukin diftitox (Ontak)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2019-11-08
        Nov 8, 2019
        M
        Completed
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +18 more
        • Scottsdale, Arizona
        • +1 more
        2020-09-28
        Sep 28, 2020
        M
        Terminated
        • Blastic Plasmacytoid Dendritic Cell Neoplasm
        • +16 more
        • Laboratory Biomarker Analysis
        • Nivolumab
        • Rochester, Minnesota
          Mayo Clinic
        2020-04-20
        Apr 20, 2020
        C
        Active, not recruiting
        • Adult T-Cell Leukemia/Lymphoma
        • +10 more
        • Brentuximab Vedotin
        • +7 more
        • Duarte, California
        • +4 more
        2021-08-10
        Aug 10, 2021